Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Johnson & Johnson Sets $55B Investment Plan to Build Next-Gen Manufacturing Facilities
Johnson Johnson has announced plans to invest more than $55 billion in the United States over the next four years This marks a 25 percent increase compared to the companys previous fouryear investment period
CordenPharma Invests >€1 billion to Expand its Greenfield Facility
CordenPharma has announced plans to invest more than 1 billion over the next three years to build and expand peptide manufacturing facilities across Europe and the United States
AstraZeneca Invests C$820 Million to Advance Global Hub & Clinical Delivery
AstraZeneca, a global pharmaceutical company focused on developing innovative medicines, has announced an investment of C$820 million US$570 million in Canada This investment aims to create over 700 highly skilled jobs across various business areas and support
Orano Med Invests €250 Million in New Facility for Lead-212 Radioligand Therapy Precursors
Orano Med, part of the Orano Group and a leader in the development of targeted alpha therapies for cancer treatment, has marked the groundbreaking of its Advanced Thorium Extraction Facility ATEF in France
BioCentriq Invests $12 Million to Expand Princeton Manufacturing Facility
BioCentriq, a prominent contract development and manufacturing organization CDMO specializing in cell therapy, has signed a longterm lease agreement with National Business Parks for a cuttingedge manufacturing facility in Princeton, New Jersey This facility will become BioCentriqs new headquarters and is set to receive a $12M capital investment for...
AstraZeneca Invests $1.5 Billion to Construct Antibody Drug Conjugate Facility in Singapore
AstraZeneca has announced a significant investment of $15 billion to establish a stateoftheart manufacturing facility in Singapore, dedicated to the production of AntibodyDrug Conjugates ADCs This facility will play a pivotal role in advancing the companys efforts to deliver cuttingedge cancer treatments
Merck Invests €70 Million to Expand ADC Manufacturing for Cancer Therapies in the U.S.
Merck Company has announced 70 million to expand its ADC manufacturing capabilities in the USA This expansion will significantly increase capacity, tripling the current levels, and strengthen the companys contract development and manufacturing organization
Piramal Pharma Invests $80 Million to Expand Sterile Injectable Facility in Kentucky
Piramal Pharma Solutions PPS is investing $80M to expand its Lexington, Kentucky facility This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization The expansion will support PPSs ADCelerate
AstraZeneca Invests $3.5 Billion to Expand R&D and Manufacturing in the U.S
AstraZeneca has unveiled plans for a $35 billion capital investment in the United States to enhance its research and manufacturing capabilities This initiative includes $2 billion allocated to new projects, which are set to generate over a thousand highskilled jobs, bolstering
Grünenthal Invests €80 Million to Enhance Latin American Production
Grnenthal, a prominent pharmaceutical company specializing in pain management and research, has announced a significant investment in its Latin American production facilities, exceeding 80 million
